CHINESE ACADEMY OF SCIENCES;GUANGZHOU INSTITUTE OF BIOMEDICINE AND HEALTH
发明人:
DING, KE,WONG, CHIWAI,PENG, LIJIE,KANG, ZHANFANG,ZHOU, XI
申请号：
CA2739379
公开号：
CA2739379C
申请日:
2009.03.06
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The compounds according to formula (I), their pharmaceutically acceptable acidor baseaddition salts, and the uses thereof. These compounds and theirpharmaceutically acceptableacid or base addition salts can be used for preparing medicaments formodulating estrogenrelated receptors (ERR), and treating metabolic diseases, such as high bloodfat, fatty liver,hyperglycemia, diabetes, obesity. The substituents of the formula are definedin thedescription.(see formula I)
